^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    DYP688

    i
    Other names: DYP688
    Associations
    News
    Trials
    Company:
    Novartis
    Drug class:
    GNAQ inhibitor, GNA11 antagonist, gp100-targeted antibody-drug conjugate
    Related drugs:
    Associations
    News
    Trials